Drug Manufacturing in Space: How Microgravity is Revolutionizing Pharmaceutical Development
NASA's decades-long research on microgravity's impact on drug development has accelerated with the International Space Station. Discover how space-bas...
Xeber.world
cancer treatment
- electric vehicles
- automotive industry
- Stellantis
- collector cars
- automotive history
- Limited Edition
- classic cars
- Mecum Auctions
- supercar
- Formula 1
- Donald Trump
- AI ethics
- U.S. China relations
- AI adoption
- AI regulation
- artificial intelligence
- Trump administration
- inflation
- AI governance
- AI in business
- Bitcoin
- crypto regulation
- Senate Banking Committee
- CLARITY Act
- digital assets
- Digital Asset Market Clarity Act
- Federal Reserve
- Bitcoin price
- Bitcoin ETF
- crypto market
- AI cybersecurity
- cybersecurity
- CISA
- enterprise security
- CVE-2026-41089
- CVE-2026-41096
- Canvas data breach
- Instructure
- House Homeland Security Committee
- Donald Trump
- Netflix
- late-night TV
- Disney
- Paramount
- Cannes Film Festival
- Stephen Colbert
- Prime Video
- Jimmy Kimmel
- Marvel
- climate change
- renewable energy
- energy policy
- AI data centers
- geothermal energy
- Fervo Energy
- U.S. energy policy
- Strait of Hormuz
- Jason Bordoff
- Texas drought
- Subnautica 2
- Phasmophobia
- gaming news
- R.E.P.O.
- Forza Horizon 6
- FC 26
- Subnautica 2 tips
- Subnautica 2 guide
- Alan Wake event
- Destructoid
- FDA
- public health
- Marty Makary
- Trump administration
- healthcare policy
- Kyle Diamantas
- hantavirus
- health policy
- FDA leadership
- gene therapy
- Donald Trump
- Trump administration
- Supreme Court
- gerrymandering
- Iran war
- Voting Rights Act
- 2024 election
- Republican Party
- Virginia Supreme Court
- redistricting
- AI ethics
- climate change
- Elon Musk
- OpenAI
- ChatGPT
- tech industry
- Tesla
- remote sensing
- AI in the workplace
- generative AI
Right to Try Law Fails Patients Despite FDA Rejection of RP1 Melanoma Therapy
The FDA’s rejection of RP1, an experimental melanoma treatment, highlights the limitations of the 2018 Right to Try Act. Despite its promise to grant...
Dave Coulier Reveals Health Struggles and Recovery After Cancer Treatments
Dave Coulier, star of 'Full House,' shared a health update on Instagram after undergoing extensive radiation for throat carcinoma. The treatments led...
Color Health Expands Virtual Cancer Care with AI-Driven Tumor Boards to Address Rising Demand
Color Health CEO Othman Laraki argues that cancer care faces a scaling crisis due to rising patient numbers, oncologist shortages, and exploding costs...
Study Reveals How Extra Chromosomes Drive Aggressive Cancer Spread
New research from Tulane University shows that extra chromosomes in cancer cells trigger a stress response, enhancing their mobility and ability to in...
Erasca’s RAS-Targeting Pill Shows Strong Early Results in Pancreatic and Lung Cancer Trials
Erasca’s RAS-targeting pill, ERAS-0015, reduced tumors in 40% of advanced pancreatic cancer patients and 62% of advanced non-small cell lung cancer pa...
Groundbreaking Study Reveals How Tumors Use Glutathione as Fuel, Opening New Avenues for Cancer Treatment
A study published in Nature reveals that cancer cells consume the antioxidant glutathione as fuel, challenging prior assumptions about its role. Resea...
Eli Lilly Acquires Kelonia Therapeutics in $3.2B Deal: How a Struggling Startup Secured a Biotech Giant's Takeover
Eli Lilly has agreed to acquire Kelonia Therapeutics, a cancer and autoimmune cell therapy startup, for $3.2 billion with potential milestone payments...
Why Emergency Department Boarding Is a Growing Crisis in U.S. Hospitals
A doctor’s husband refused emergency care due to traumatic experiences with hospital boarding. His story highlights the worsening crisis of patients s...
Alyssa Farah Griffin Slams RFK Jr.’s AI Cancer Cure Claim on 'The View'
Alyssa Farah Griffin criticized RFK Jr.’s Senate testimony claiming AI cured a dog’s cancer, calling him an unqualified expert. She also highlighted h...
Can Erasca Challenge Revolution Medicines as the Next Big Player in Pancreatic Cancer Treatment?
Erasca, valued at nearly $7 billion, is racing to prove its pan-RAS inhibitor ERAS-0015 could rival Revolution Medicines in pancreatic cancer treatmen...
Metformin May Match Exercise Benefits in Prostate Cancer Patients by Boosting 'Exercise Molecule'
A new study reveals that the diabetes drug metformin may mimic a key effect of exercise in prostate cancer patients by increasing levels of an 'exerci...